149 related articles for article (PubMed ID: 22491408)
1. Aquaporin changes during diabetic retinopathy in rats are accelerated by systemic hypertension and are linked to the renin-angiotensin system.
Qin Y; Ren H; Hoffman MR; Fan J; Zhang M; Xu G
Invest Ophthalmol Vis Sci; 2012 May; 53(6):3047-53. PubMed ID: 22491408
[TBL] [Abstract][Full Text] [Related]
2. High-salt loading exacerbates increased retinal content of aquaporins AQP1 and AQP4 in rats with diabetic retinopathy.
Qin Y; Xu G; Fan J; Witt RE; Da C
Exp Eye Res; 2009 Nov; 89(5):741-7. PubMed ID: 19596320
[TBL] [Abstract][Full Text] [Related]
3. Effect of beta-adrenergic and renin-angiotensin system blockade on myocyte apoptosis and oxidative stress in diabetic hypertensive rats.
Fiordaliso F; De Angelis N; Bai A; Cuccovillo I; Salio M; Serra DM; Bianchi R; Razzetti R; Latini R; Masson S
Life Sci; 2007 Sep; 81(12):951-9. PubMed ID: 17825849
[TBL] [Abstract][Full Text] [Related]
4. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
5. Exogenous SOD mimetic tempol ameliorates the early retinal changes reestablishing the redox status in diabetic hypertensive rats.
Rosales MA; Silva KC; Lopes de Faria JB; Lopes de Faria JM
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4327-36. PubMed ID: 20335612
[TBL] [Abstract][Full Text] [Related]
6. High salt loading alters the expression and localization of glial aquaporins in rat retina.
Qin Y; Fan J; Ye X; Xu G; Liu W; Da C
Exp Eye Res; 2009 Jun; 89(1):88-94. PubMed ID: 19268466
[TBL] [Abstract][Full Text] [Related]
7. Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol.
Phipps JA; Wilkinson-Berka JL; Fletcher EL
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):927-34. PubMed ID: 17251496
[TBL] [Abstract][Full Text] [Related]
8. Glial reactivity, an early feature of diabetic retinopathy.
Rungger-Brändle E; Dosso AA; Leuenberger PM
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1971-80. PubMed ID: 10845624
[TBL] [Abstract][Full Text] [Related]
9. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
11. A decrease in retinal progenitor cells is associated with early features of diabetic retinopathy in a model that combines diabetes and hypertension.
Lopes de Faria JM; Silva KC; Boer PA; Cavalcanti TC; Rosales MA; Ferrari AL; Lopes de Faria JB
Mol Vis; 2008 Sep; 14():1680-91. PubMed ID: 18806882
[TBL] [Abstract][Full Text] [Related]
12. Hypertension increases retinal inflammation in experimental diabetes: a possible mechanism for aggravation of diabetic retinopathy by hypertension.
Silva KC; Pinto CC; Biswas SK; de Faria JB; de Faria JM
Curr Eye Res; 2007 Jun; 32(6):533-41. PubMed ID: 17612969
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats.
Rizzoni D; Pasini E; Flati V; Rodella LF; Paiardi S; Assanelli D; De Ciuceis C; Porteri E; Boari GE; Rezzani R; Speca S; Favero G; Martinotti S; Toniato E; Platto C; Agabiti-Rosei E
J Hypertens; 2008 Aug; 26(8):1595-601. PubMed ID: 18622238
[TBL] [Abstract][Full Text] [Related]
14. Prevention of hypertension abrogates early inflammatory events in the retina of diabetic hypertensive rats.
Silva KC; Pinto CC; Biswas SK; Souza DS; de Faria JB; de Faria JM
Exp Eye Res; 2007 Jul; 85(1):123-9. PubMed ID: 17493613
[TBL] [Abstract][Full Text] [Related]
15. Early retinal damage in experimental diabetes: electroretinographical and morphological observations.
Li Q; Zemel E; Miller B; Perlman I
Exp Eye Res; 2002 May; 74(5):615-25. PubMed ID: 12076083
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
Zheng Z; Chen H; Xu X; Li C; Gu Q
Exp Eye Res; 2007 Apr; 84(4):745-52. PubMed ID: 17303121
[TBL] [Abstract][Full Text] [Related]
17. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
[TBL] [Abstract][Full Text] [Related]
18. Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.
Prasad T; Roksnoer LC; Zhu P; Verma A; Li Y; Batenburg WW; de Vries R; Danser AH; Li Q
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6722-6730. PubMed ID: 27951594
[TBL] [Abstract][Full Text] [Related]
19. Reduction of inducible nitric oxide synthase via angiotensin receptor blocker prevents the oxidative retinal damage in diabetic hypertensive rats.
Silva KC; Rosales MA; de Faria JB; de Faria JM
Curr Eye Res; 2010 Jun; 35(6):519-28. PubMed ID: 20465447
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
